U. Ilgen Et Al. , "Fetal exposure to canakinumab: a report of three pregnancies," CLINICAL RHEUMATOLOGY , vol.41, no.4, pp.1261-1263, 2022
Ilgen, U. Et Al. 2022. Fetal exposure to canakinumab: a report of three pregnancies. CLINICAL RHEUMATOLOGY , vol.41, no.4 , 1261-1263.
Ilgen, U., Eyupoglu, S., Yayla, M. E., & KÜÇÜKŞAHİN, O., (2022). Fetal exposure to canakinumab: a report of three pregnancies. CLINICAL RHEUMATOLOGY , vol.41, no.4, 1261-1263.
Ilgen, Ufuk Et Al. "Fetal exposure to canakinumab: a report of three pregnancies," CLINICAL RHEUMATOLOGY , vol.41, no.4, 1261-1263, 2022
Ilgen, Ufuk Et Al. "Fetal exposure to canakinumab: a report of three pregnancies." CLINICAL RHEUMATOLOGY , vol.41, no.4, pp.1261-1263, 2022
Ilgen, U. Et Al. (2022) . "Fetal exposure to canakinumab: a report of three pregnancies." CLINICAL RHEUMATOLOGY , vol.41, no.4, pp.1261-1263.
@article{article, author={Ufuk Ilgen Et Al. }, title={Fetal exposure to canakinumab: a report of three pregnancies}, journal={CLINICAL RHEUMATOLOGY}, year=2022, pages={1261-1263} }